LSE - Small Logo
LSE - Small Logo

Dipa Patel20

February 14th, 2019

Brazil’s Fight against Hepatitis C — Universalism, Local Production, and Patents

0 comments

Estimated reading time: 5 minutes

Dipa Patel20

February 14th, 2019

Brazil’s Fight against Hepatitis C — Universalism, Local Production, and Patents

0 comments

Estimated reading time: 5 minutes

In his recent short essay for the New England Journal of Medicine, Professor Ken Shadlen and co-authors examine three aspects of Brazili’s pioneering approach to the treatment of Hepatitis C virus (HCV). 

Brazil has been a pioneer in AIDS treatment, expanding access to key drugs and care. It has served as a model for other developing countries, showing that prevention and care can be extended even in resource-constrained settings. Now, Brazil is, again, paving the way in treatment of Hepatitis C virus (HCV). In a new “Perspective” in the New England Journal of Medicine, we examine three aspects of Brazili’s approach to HCV: treatment guidelines, innovative measures to enhance manufacturing capabilities for local production of key drugs, and key issues related to pharmaceutical patents on these drugs. We show how these dimensions relate to each other. For example, expansion of treatment makes the Ministry of Health acutely concerned with drug prices and the availability of local suppliers. Yet the patent situation complicates the ability of local suppliers to enter the market. A key aspect of Brazil’s strategy is to assure that the capability for local production exists, so to arm the government with an important bargaining chip in price negotiations.

You can read the full essay here.


Professor Ken Shadlen is Professor in Development Studies and Head of Department in the Department of International Development at the LSE. He works on the comparative and international political economy of development, with a focus on understanding variation in national policy responses to changing global rules. In recent years his research has focused on the global and cross-national politics of intellectual property (IP). He is also the author of Coalitions and Compliance: The Political Economy of Pharmaceutical Patents in Latin America (OUP, 2017).

The views expressed in this post are those of the author and in no way reflect those of the International Development LSE blog or the London School of Economics and Political Science.

About the author

Dipa Patel20

Posted In: Featured | Publications

Leave a Reply

Your email address will not be published. Required fields are marked *

RSS Justice and Security Research Programme

RSS LSE’s engagement with South Asia

  • Leading by Example: Bangladesh’s Response to Humanitarian Crises in South Asia and Beyond
    Bangladesh has long held an image of poverty, deprivation and corruption in the minds of many. In this blogpost, Parvej Siddique Bhuiyan argues that this negative image in fact overlooks Bangladesh’s humanitarian activities both in South Asia as well as other countries, often when other more affluent and resource-equipped nations have not risen to the […]
  • The Struggles, Victories and Debates on Human Rights in Pakistan
    What is the status of human rights and civil liberties in Pakistan today? As the country celebrates 75 years, Farah Zia outlines its complex history of struggle and victories in a country whose complicated political trajectory over the past seven decades seems to distance it more and more from the vision of its Founding Father […]